Velocity Global Establishes Asia-Pacific Headquarters in Singapore; Appoints Nicholas Yap as Managing Director
Velocity Global clients grow more than 30% in APAC this year Company plans to add…
6 years ago
NeuClone Announces Positive Results from Phase I Study of Stelara® (ustekinumab) Biosimilar Candidate
SYDNEY--(BUSINESS WIRE)--NeuClone Pharmaceuticals Ltd (NeuClone) today announced its biosimilar candidate of Stelara® (ustekinumab), NeuLara, has…
6 years ago
Skyhook and Unwired Announce Cooperation to Provide Integrated Location Services
BOSTON--(BUSINESS WIRE)--Skyhook Wireless, Inc. (“Skyhook”), the pioneer in the development of Wi-Fi positioning technology, and…
6 years ago
Bridge Expands to Asia with Seoul Office Opening
NEW YORK--(BUSINESS WIRE)--Bridge Investment Group (“Bridge”) today announced that it has opened an office in…
6 years ago
Aberdeen’s green stone coating expands into USA
TAIPEI, TAIWAN - Media OutReach - 20 October 2020 - The faux stone coating for buildings,…
6 years ago
Yamaha YVC-330 Speakerphone Certified by Zoom
The Intelligent Speakerphone Received Zoom Certification to Deliver Frictionless Deployment and Superior Audio Experience in…
6 years ago
Aegis Software and Enlight Technology Form Reseller Partnership in Taiwan
Enlight Technology has Signed a Distribution Agreement with Aegis to Sell the FactoryLogix Manufacturing Operations…
6 years ago
Hop along to PlayCroco for Frog Fortunes
SYDNEY--(BUSINESS WIRE)--It’s time to put those animal instincts into action as Frog Fortunes becomes the…
6 years ago
China Construction Trends and Opportunities Report 2020-2024: Market is Still Expected to Grow in 2020 Despite the Severe Disruptions Caused by COVID-19 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Construction in China - Key Trends and Opportunities to 2024" report has been…
6 years ago
Nevakar and Zhaoke Ophthalmology Enter into Licensing Agreement for NVK-002 (Atropine for the Treatment of the Progression of Myopia in Children)
BRIDGEWATER, N.J. & HONG KONG--(BUSINESS WIRE)--Nevakar Inc. (“Nevakar”), a privately held, late-stage, biopharmaceutical company developing…
6 years ago